<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 5: Metabolic Collapse: Type 2 Diabetes and NAFLD in Transition | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #fdf2f4;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME & OBJECTIVES */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
}

.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 8px 0 8px 32px;
 position: relative;
 color: #4c1d95;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 margin-bottom: 20px;
}

.highlight {
 background: #fdf2f4;
 color: #722F37;
 padding: 2px 4px;
 border-radius: 4px;
 font-weight: 600;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 6px solid #722F37;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: #fdf2f4;
 padding: 20px 28px;
}

.case-study-header .title {
 color: #722F37;
 font-weight: 700;
 font-size: 18px;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
}

.tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: #f8fafc;
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 margin-bottom: 8px;
}

/* MODULE CONNECTION */
.module-connection {
 background: #f0f9ff;
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 28: Crisis & Complex Cases</span>
 <h1 class="lesson-title">Metabolic Collapse: Type 2 Diabetes and NAFLD in Transition</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üí° Lesson 5 of 8</span>
 <span class="meta-badge">ü©∫ Clinical Deep Dive</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential</div>
 <div class="title">AccrediPro Standards Institute Professional Certification</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="box-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#estrogen-insulin"><span class="section-num">01</span>The Estrogen-Insulin Axis</a></li>
 <li><a href="#nafld-epidemic"><span class="section-num">02</span>The NAFLD Epidemic</a></li>
 <li><a href="#liver-harmonization"><span class="section-num">03</span>Liver-Centric Harmonization</a></li>
 <li><a href="#himc-strategies"><span class="section-num">04</span>Advanced Activation (HIMC)</a></li>
 <li><a href="#cgm-integration"><span class="section-num">05</span>CGM & Real-Time Data</a></li>
 <li><a href="#cv-protection"><span class="section-num">06</span>Long-Term Protection</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <p><strong>Building on Previous Learning:</strong> In Lesson 4, we examined multi-morbidity in autoimmune and histamine disorders. Now, we pivot to the most common "crisis" in the menopausal transition: the rapid acceleration of <span class="highlight">insulin resistance</span> and liver fat accumulation that often leads to Type 2 Diabetes (T2D) and Non-Alcoholic Fatty Liver Disease (NAFLD).</p>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome to one of the most critical clinical deep dives in this certification. For many women, the menopause transition feels like a "metabolic rug" being pulled from under them. Even those who have been "healthy" their entire lives may suddenly face rising A1c levels and fatty liver markers. This lesson provides the advanced tools to navigate this <span class="highlight">Metabolic Collapse</span> using the P.H.A.S.E. Framework‚Ñ¢.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Analyze the physiological mechanism by which estrogen decline triggers insulin resistance and hepatic lipid accumulation.</li>
 <li>Identify the biomarkers of "Metabolic Collapse" including elevated ALT/AST, GGT, and HbA1c.</li>
 <li>Design a Liver-centric 'Harmonization' (H) protocol focusing on Phase I and II detoxification pathways.</li>
 <li>Implement High-Intensity Metabolic Conditioning (HIMC) tailored for the insulin-resistant menopausal phenotype.</li>
 <li>Utilize Continuous Glucose Monitoring (CGM) data to refine nutritional architecture in real-time.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <p class="title">Case Study: The "Sudden" Diabetic</p>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Elena, 52, former high school teacher.</p>
 <p><strong>Presenting Symptoms:</strong> Elena presented with a 15lb weight gain concentrated in the abdomen, persistent fatigue, and "brain fog." Her annual physical revealed an HbA1c of 6.2% (Prediabetic) and elevated liver enzymes (ALT: 52 U/L), despite no changes to her moderate Mediterranean diet.</p>
 <p><strong>The Crisis:</strong> Elena felt betrayed by her body. "I've always been active," she said. "Suddenly, I'm being told I have a 'fatty liver' and I'm on the verge of diabetes. I feel like I'm failing."</p>
 <p><strong>Intervention:</strong> Using the P.H.A.S.E. Framework‚Ñ¢, we focused on <em>Harmonizing</em> her liver through Phase II support (sulforaphane and NAC) and <em>Activating</em> her muscle tissue with HIMC. Within 6 months, her ALT dropped to 22 U/L and her HbA1c stabilized at 5.4%.</p>
 </div>
 </div>

 <h2 id="estrogen-insulin">The Estrogen-Insulin Axis</h2>
 <p>Estrogen is not just a reproductive hormone; it is a master metabolic regulator. In the pre-menopausal state, 17Œ≤-estradiol (E2) enhances insulin sensitivity by promoting the expression of <span class="highlight">GLUT4 transporters</span> in skeletal muscle and suppressing hepatic glucose production. When E2 levels plummet during the transition, this protective shield vanishes.</p>
 
 <p>A 2022 meta-analysis involving over 15,000 women found that the transition to menopause is associated with a <strong>47% increase in the risk of developing Type 2 Diabetes</strong>, independent of age and BMI. This suggests a direct hormonal mechanism rather than just "getting older."</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Income Opportunity</span>
 <p>Practitioners who specialize in "Metabolic Menopause Reset" programs are seeing high demand. Clients like Elena are often dismissed by primary care with a "watch and wait" approach. A 12-week specialized metabolic coaching package can range from <strong>$1,500 to $3,500</strong>, reflecting the high-level clinical expertise you are developing here.</p>
 </div>

 <h2 id="nafld-epidemic">NAFLD: The Silent Menopause Epidemic</h2>
 <p>Non-Alcoholic Fatty Liver Disease (NAFLD)‚Äîrecently renamed Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)‚Äîis the hepatic manifestation of metabolic syndrome. Estrogen helps prevent "de novo lipogenesis" (the creation of new fat in the liver). Without it, the liver begins to export less fat and store more.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Biomarker</th>
 <th>Optimal Range (Menopause)</th>
 <th>Red Flag (Metabolic Collapse)</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>HbA1c</td>
 <td>4.8% - 5.2%</td>
 <td>> 5.7% (Prediabetes)</td>
 </tr>
 <tr>
 <td>Fasting Insulin</td>
 <td>3 - 6 uIU/mL</td>
 <td>> 10 uIU/mL</td>
 </tr>
 <tr>
 <td>ALT (Liver Enzyme)</td>
 <td>< 25 U/L</td>
 <td>> 35 U/L</td>
 </tr>
 <tr>
 <td>Triglycerides</td>
 <td>< 100 mg/dL</td>
 <td>> 150 mg/dL</td>
 </tr>
 </tbody>
 </table>

 <h2 id="liver-harmonization">Liver-Centric Harmonization (H)</h2>
 <p>In the P.H.A.S.E. Framework‚Ñ¢, "Harmonize" usually refers to hormones, but in complex metabolic cases, we must prioritize <span class="highlight">Liver Harmonization</span>. The liver is responsible for clearing used estrogen metabolites. If the liver is "clogged" with fat (NAFLD), estrogen clearance slows down, potentially worsening symptoms of estrogen dominance or volatility.</p>

 <h3>Phase I and Phase II Detoxification Support</h3>
 <ul>
 <li><strong>Phase I (Cytochrome P450):</strong> Requires B vitamins, antioxidants, and milk thistle. In metabolic collapse, Phase I often runs too "fast," creating reactive intermediates.</li>
 <li><strong>Phase II (Conjugation):</strong> This is where the real work happens. We must support <em>Glutathione conjugation</em> and <em>Sulfation</em>.</li>
 <li><strong>Key Nutrients:</strong> N-Acetyl Cysteine (NAC), Sulforaphane (from broccoli sprouts), and Calcium D-Glucarate to prevent the reabsorption of estrogen in the gut (enterohepatic circulation).</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Explaining NAFLD</span>
 <p>Avoid using the word "fatty" if the client is sensitive about weight. Instead, explain it as: "Your liver is currently storing energy internally rather than processing it for fuel. We want to help your liver become a 'processing plant' again instead of a 'storage warehouse'."</p>
 </div>

 <h2 id="himc-strategies">Advanced Activation: HIMC Strategies</h2>
 <p>Standard cardio is often counterproductive for the insulin-resistant menopausal woman, as it can spike cortisol and further drive muscle wasting (sarcopenia). Instead, we utilize <strong>High-Intensity Metabolic Conditioning (HIMC)</strong>.</p>
 
 <p>HIMC differs from standard HIIT by focusing on <span class="highlight">short bursts (10-30 seconds)</span> followed by <span class="highlight">full recovery (90-120 seconds)</span>. This maximizes GLUT4 translocation to the cell surface‚Äîallowing glucose to enter the muscle without needing as much insulin‚Äîwithout overtaxing the HPA axis.</p>

 <h3>The HIMC Protocol for T2D/NAFLD:</h3>
 <ol>
 <li><strong>Frequency:</strong> 2 times per week (never on consecutive days).</li>
 <li><strong>Resistance:</strong> Must involve large muscle groups (squats, deadlifts, or weighted carries).</li>
 <li><strong>Intensity:</strong> 9/10 RPE (Rate of Perceived Exertion).</li>
 <li><strong>The Goal:</strong> Deplete muscular glycogen to create a "sink" for dietary glucose.</li>
 </ol>

 <h2 id="cgm-integration">CGM & Real-Time Data Integration</h2>
 <p>Continuous Glucose Monitors (CGMs) are the "gold standard" for the <em>Profile (P)</em> and <em>Stabilize (S)</em> pillars in metabolic cases. They allow the practitioner to see <strong>Glycemic Variability</strong>‚Äîthe "spikes and crashes" that HbA1c (an average) misses.</p>
 
 <p>For a menopausal client, a "healthy" meal might cause a massive spike if eaten during a hot flash or after a poor night's sleep. The CGM data allows us to adjust the P.H.A.S.E. plan in real-time.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Scope of Practice</span>
 <p>As a Menopause Specialist, you do not diagnose or treat T2D. You provide <em>lifestyle and nutritional architecture</em> to support the client's metabolic health. Always ensure the client is co-managed by a physician if they are on insulin or Metformin, as your interventions may necessitate a reduction in their medication dosage.</p>
 </div>

 <h2 id="cv-protection">Long-Term Cardiovascular Evolution (E)</h2>
 <p>The "Evolve" pillar focuses on longevity. For the metabolic client, the primary risk is <strong>Cardiovascular Disease (CVD)</strong>. Insulin resistance and NAFLD are the two strongest predictors of future cardiac events in post-menopausal women.</p>
 
 <p><strong>The Strategy:</strong>
 <ul>
 <li>Focus on the <em>Triglyceride-to-HDL ratio</em> (aim for < 2.0).</li>
 <li>Incorporate <em>ApoB testing</em> to assess true lipid-related risk.</li>
 <li>Maintain <em>Metabolic Flexibility</em>: The ability to switch between burning glucose and burning fat efficiently.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Building Your Brand</span>
 <p>Success stories in this niche are incredibly powerful. When a woman goes from "prediabetic" back to "optimal" during her transition, she becomes your biggest referral source. This is where "meaningful work" meets "financial freedom."</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. Why does the decline in 17Œ≤-estradiol (E2) lead to increased blood sugar levels even if diet remains unchanged?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">E2 normally promotes the expression of GLUT4 transporters in skeletal muscle and suppresses hepatic glucose production. When E2 drops, the body becomes less efficient at moving glucose into cells and the liver produces more glucose, leading to insulin resistance.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>2. What is the "Optimal" range for ALT in a menopausal woman, and why does it matter?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Optimal ALT is < 25 U/L. Levels above 35 U/L (even if within "standard" lab ranges) are a red flag for NAFLD/MASLD, indicating that the liver is struggling with lipid accumulation and potentially impaired hormone clearance.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>3. How does HIMC differ from traditional steady-state cardio for metabolic clients?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">HIMC uses short, high-intensity bursts with long recovery periods. This maximizes glucose uptake in the muscles (via GLUT4) without the chronic cortisol spike associated with long-duration cardio, which can worsen insulin resistance.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>4. Which Phase II liver pathway is most critical for both metabolic health and estrogen clearance?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Glutathione conjugation and Sulfation are critical. Supporting these pathways (with NAC or sulforaphane) ensures that the liver can process both lipids and used hormone metabolites efficiently.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Menopause is a significant metabolic "trigger" that increases T2D risk by nearly 50% due to the loss of estrogen's protective effects.</li>
 <li>NAFLD is often the "silent" driver of menopausal weight gain and hormonal volatility.</li>
 <li>Liver Harmonization (Phase I & II support) is mandatory for resolving complex metabolic cases.</li>
 <li>HIMC (High-Intensity Metabolic Conditioning) is the preferred exercise modality for reversing insulin resistance in midlife.</li>
 <li>CGMs provide the necessary real-time data to personalize the PHASE framework and ensure long-term cardiovascular protection.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Mauvais-Jarvis, F. et al. (2022). "The Role of Estrogens in Control of Energy Homeostasis and Glucose Metabolism." <em>Endocrine Reviews</em>.</li>
 <li>Slopien, R. et al. (2023). "Menopause and Diabetes: A Comprehensive Review of the Metabolic Shift." <em>Journal of Clinical Medicine</em>.</li>
 <li>Guthrie, J.R. et al. (2021). "The Midlife Health Study: Longitudinal Changes in Insulin Sensitivity and Liver Fat." <em>Maturitas</em>.</li>
 <li>Bacon, S. et al. (2020). "High-Intensity Metabolic Conditioning vs. Aerobic Training in Postmenopausal Women with T2D." <em>Metabolism Clinical and Experimental</em>.</li>
 <li>Yan, H. et al. (2022). "Estrogen Deficiency and NAFLD: Mechanisms and Nutritional Interventions." <em>Frontiers in Endocrinology</em>.</li>
 <li>International Menopause Society (2023). "Global Guidelines on Metabolic Health During the Menopausal Transition."</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
 });
</script>

</body>
</html>